Document Detail


Left ventricular function of isoproterenol-induced hypertrophied rat hearts perfused with blood: mechanical work and energetics.
MedLine Citation:
PMID:  19734357     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
We investigated left ventricular (LV) mechanical work and energetics in the cross-circulated (blood-perfused) isoproterenol [Iso 1.2 mg x kg(-1).day(-1) for 3 days (Iso3) or 7 days (Iso7)]-induced hypertrophied rat heart preparation under isovolumic contraction-relaxation. We evaluated pressure-time curves per beat, end-systolic pressure-volume and end-diastolic pressure-volume relations, and myocardial O(2) consumption per beat (Vo(2))-systolic pressure-volume area (PVA; a total mechanical energy per beat) linear relations at 240 beats/min, because Iso-induced hypertrophied hearts failed to completely relax at 300 beats/min. The LV relaxation rate at 240 beats/min in Iso-induced hypertrophied hearts was significantly slower than that in control hearts [saline 24 microl/day for 3 and 7 days (Sa)] with unchanged contraction rate. The Vo(2)-intercepts (composed of basal metabolism and Ca(2+) cycling energy consumption in excitation-contraction coupling) of Vo(2)-PVA linear relations were unchanged associated with their unchanged slopes in Sa, Iso3, and Iso7 groups. The oxygen costs of LV contractility were also unchanged in all three groups. The amounts of expression of sarcoplasmic reticulum Ca(2+)-ATPase, phospholamban (PLB), phosphorylated-Ser(16) PLB, phospholemman, and Na(+)-K(+)-ATPase are significantly decreased in Iso3 and Iso7 groups, although the amount of expression of NCX1 is unchanged in all three groups. Furthermore, the marked collagen production (types I and III) was observed in Iso3 and Iso7 groups. These results suggested the possibility that lowering the heart rate was beneficial to improve mechanical work and energetics in isoproterenol-induced hypertrophied rat hearts, although LV relaxation rate was slower than in normal hearts.
Authors:
Chikako Nakajima-Takenaka; Guo-Xing Zhang; Koji Obata; Kiyoe Tohne; Hiroko Matsuyoshi; Yukiko Nagai; Akira Nishiyama; Miyako Takaki
Related Documents :
18307437 - Preload dependence of the time interval between onsets of mitral inflow and early diast...
16783487 - Impaired systolic torsion in dilated cardiomyopathy: reversal of apical rotation at mid...
6869277 - Determinants of circulatory response to intravenous hydralazine in congestive heart fai...
20218917 - Impaired midwall mechanics and biventricular hypertrophy in essential hypertension.
25191037 - Association of premature androgenetic alopecia and metabolic syndrome in a young indian...
8111667 - The role of itp-dag regulatory cascade in the mechanism of cardioprotective effect of a...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2009-09-04
Journal Detail:
Title:  American journal of physiology. Heart and circulatory physiology     Volume:  297     ISSN:  1522-1539     ISO Abbreviation:  Am. J. Physiol. Heart Circ. Physiol.     Publication Date:  2009 Nov 
Date Detail:
Created Date:  2009-10-27     Completed Date:  2009-11-12     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100901228     Medline TA:  Am J Physiol Heart Circ Physiol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  H1736-43     Citation Subset:  IM    
Affiliation:
Department of Physiology II, Nara Medical University, 840 Shijo-cho, Kashihara, Nara, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adrenergic beta-Agonists / administration & dosage
Animals
Blood Pressure
Blotting, Western
Calcium-Binding Proteins / metabolism
Cardiomegaly / chemically induced,  metabolism*,  physiopathology*
Collagen Type I / genetics,  metabolism
Collagen Type III / genetics,  metabolism
Coronary Circulation
Disease Models, Animal
Energy Metabolism*
Heart Rate
Infusion Pumps, Implantable
Isoproterenol / administration & dosage
Male
Membrane Proteins / metabolism
Myocardial Contraction*
Myocardium / metabolism*
Oxygen Consumption*
Perfusion
Phosphoproteins / metabolism
Phosphorylation
Polymerase Chain Reaction
RNA, Messenger / metabolism
Rats
Rats, Wistar
Sarcoplasmic Reticulum Calcium-Transporting ATPases / metabolism
Serine
Sodium-Calcium Exchanger / metabolism
Sodium-Potassium-Exchanging ATPase / metabolism
Time Factors
Ventricular Function, Left*
Ventricular Pressure
Chemical
Reg. No./Substance:
0/Adrenergic beta-Agonists; 0/Calcium-Binding Proteins; 0/Collagen Type I; 0/Collagen Type III; 0/Membrane Proteins; 0/Phosphoproteins; 0/RNA, Messenger; 0/Sodium-Calcium Exchanger; 0/phospholamban; 0/sodium-calcium exchanger 1; 135541-82-1/phospholemman; 56-45-1/Serine; 7683-59-2/Isoproterenol; EC 3.6.3.8/Sarcoplasmic Reticulum Calcium-Transporting ATPases; EC 3.6.3.9/Sodium-Potassium-Exchanging ATPase

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  VEGF-C regulates lymphangiogenesis and capillary stability by regulation of PDGF-B.
Next Document:  Angiotensin II, mechanotransduction, and pulsatile arterial hemodynamics in hypertension.